Pharma Acquisitions- What will happen this year?
Valeant Pharmaceuticals International today announced over the Christmas Break that the company completed its acquisition of Dow Pharmaceutical Sciences, Inc, a privately held dermatology company that
By on Jan 5, 2009Valeant Pharmaceuticals International today announced over the Christmas Break that the company completed its acquisition of Dow Pharmaceutical Sciences, Inc, a privately held dermatology company that specializes in the development of topical products on a proprietary basis, as well as for pharmaceutical and biotechnology companies.
Is this a sign for things to come this year? Will there be more moves into biotech? Or will pharma focus on the emerging markets?